Net Cash Provided by (Used in) Financing Activities of MAXCYTE, INC. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
MAXCYTE, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • MAXCYTE, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $383,000, a 46% decline year-over-year.
  • MAXCYTE, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $2,056,000, a 4.1% decline from 2023.
  • MAXCYTE, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2,143,000, a 26% decline from 2022.
  • MAXCYTE, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,888,000, a 99% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

MAXCYTE, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $383,000 -$320,000 -46% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $703,000 -$753,000 -52% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $1,456,000 +$563,400 +63% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $892,600 -$48,006,500 -98% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $48,899,100 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1

MAXCYTE, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,056,000 -$87,000 -4.1% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $2,143,000 -$745,000 -26% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $2,888,000 -$231,832,000 -99% 01 Jan 2022 31 Dec 2022 10-K 12 Mar 2024 2023 FY
2021 $234,720,000 +$205,815,500 +712% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $28,904,500 +$16,593,700 +135% 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022 2021 FY
2019 $12,310,800 01 Jan 2019 31 Dec 2019 10-K 22 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.